ByMedullaxFebruary 7, 2026 AI Method Links CXR Evidence to CT Quantification for ILD Diagnosis Clinical AI & Diagnostics
ByMedullaxFebruary 7, 2026 MHRA Highlights Rare NAION Risk with Semaglutide (Wegovy, Ozempic, Rybelsus) Government & Funding Research & Evidence
ByMedullaxFebruary 7, 2026 AI Model Predicts Intracranial Aneurysm Hemodynamics in Real Time Clinical AI & Diagnostics
ByMedullaxFebruary 2, 2026 Speech-based digital biomarkers: A new frontier for cognitive impairment assessment Clinical AI & Diagnostics
ByMedullaxFebruary 1, 2026 New initiative aims to boost rare cancer patient access to breakthrough trials Government & Funding
ByMedullaxJanuary 30, 2026 Pancreatitis Risk: GLP-1 Agonist Warnings Strengthened Following Fatal Cases Government & Funding Research & Evidence
ByMedullaxJanuary 30, 2026 UKRI Allocates £3M to Boost Diet and Health Innovation in UK Healthcare Government & Funding UK HealthTech & Deals
ByMedullaxJanuary 29, 2026 NHS to roll out enhanced bowel cancer screening for earlier detection NHS & Policy
ByMedullaxJanuary 28, 2026 AI and optimisation enhance operating theatre efficiency for arthroplasty Research & Evidence
ByMedullaxJanuary 28, 2026 UKRI-Supported ‘Fixing Our Broken Planet’ Exhibition Engages Over 2 Million Government & Funding
